About Origin recognition complex subunit 4
Origin recognition complex subunit 4 (ORC4) is a protein
from Homo sapiens identified by UniProt accession
O43929, 436 residues long.
MolForge cross-references it against 0 known binders and
76 disease associations.
Target properties
| Protein name | Origin recognition complex subunit 4 |
| UniProt accession | O43929 |
| Gene | ORC4 |
| Organism | Homo sapiens |
| Length | 436 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (76)
Diseases linked to this target (Open Targets).
- Ear-patella-short stature syndrome · score 0.78
- microcephalic primordial dwarfism · score 0.37
- diastolic blood pressure · score 0.34
- urate measurement · score 0.31
- monocyte count · score 0.30
- glomerular filtration rate · score 0.28
- sex hormone-binding globulin measurement · score 0.28
- basophil count · score 0.28
- body height · score 0.26
- basophil percentage of leukocytes · score 0.24
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O43929-F1 | alphafold | PREDICTED | 85.89 | — |
Amino-acid sequence (436 residues)
MSSRKSKSNS LIHTECLSQV QRILRERFCR QSPHSNLFGV QVQYKHLSEL LKRTALHGES NSVLIIGPRG SGKTMLINHA LKELMEIEEV SENVLQVHLN GLLQINDKIA LKEITRQLNL ENVVGDKVFG SFAENLSFLL EALKKGDRTS SCPVIFILDE FDLFAHHKNQ TLLYNLFDIS QSAQTPIAVI GLTCRLDILE LLEKRVKSRF SHRQIHLMNS FGFPQYVKIF KEQLSLPAEF PDKVFAEKWN ENVQYLSEDR SVQEVLQKHF NISKNLRSLH MLLMLALNRV TASHPFMTAV DLMEASQLCS MDSKANIVHG LSVLEICLII AMKHLNDIYE EEPFNFQMVY NEFQKFVQRK AHSVYNFEKP VVMKAFEHLQ QLELIKPMER TSGNSQREYQ LMKLLLDNTQ IMNALQKYPN CPTDVRQWAT SSLSWL
Explore Origin recognition complex subunit 4 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets